As of 2024-07-27, the Relative Valuation of Mesa Laboratories Inc (MLAB) is (1,559.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 110.02 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -1517.1%.
The range of the Relative Valuation is (1,592.22) - (1,547.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 33.9x - 41.0x | 36.2x |
| Forward P/E multiples | 25.7x - 32.9x | 30.2x |
| Fair Price | (1,592.22) - (1,547.10) | (1,559.08) |
| Upside | -1547.2% - -1506.2% | -1517.1% |
| Date | P/E |
| 2024-07-26 | -2.34 |
| 2024-07-25 | -2.30 |
| 2024-07-24 | -2.31 |
| 2024-07-23 | -2.41 |
| 2024-07-22 | -2.36 |
| 2024-07-19 | -2.30 |
| 2024-07-18 | -2.29 |
| 2024-07-17 | -2.39 |
| 2024-07-16 | -2.41 |
| 2024-07-15 | -2.19 |
| 2024-07-12 | -2.25 |
| 2024-07-11 | -2.23 |
| 2024-07-10 | -2.00 |
| 2024-07-09 | -1.97 |
| 2024-07-08 | -2.02 |
| 2024-07-05 | -1.95 |
| 2024-07-03 | -1.92 |
| 2024-07-02 | -1.87 |
| 2024-07-01 | -1.88 |
| 2024-06-28 | -1.85 |
| 2024-06-27 | -1.81 |
| 2024-06-26 | -1.88 |
| 2024-06-25 | -1.91 |
| 2024-06-24 | -1.94 |
| 2024-06-21 | -1.97 |
| 2024-06-20 | -1.95 |
| 2024-06-18 | -1.94 |
| 2024-06-17 | -1.95 |
| 2024-06-14 | -1.95 |
| 2024-06-13 | -1.98 |
| 2024-06-12 | -2.03 |
| 2024-06-11 | -2.03 |
| 2024-06-10 | -2.13 |
| 2024-06-07 | -2.23 |
| 2024-06-06 | -2.28 |
| 2024-06-05 | -2.28 |
| 2024-06-04 | -2.02 |
| 2024-06-03 | -1.98 |
| 2024-05-31 | -2.04 |
| 2024-05-30 | -2.35 |
| 2024-05-29 | -2.49 |
| 2024-05-28 | -2.43 |
| 2024-05-24 | -2.38 |
| 2024-05-23 | -2.40 |
| 2024-05-22 | -2.43 |
| 2024-05-21 | -2.52 |
| 2024-05-20 | -2.59 |
| 2024-05-17 | -2.60 |
| 2024-05-16 | -2.57 |
| 2024-05-15 | -2.52 |